Evidence map›Paper›PMID 20194621›Full record

ArticleMolecular and cellular biology2010

Human mitochondrial leucyl-tRNA synthetase corrects mitochondrial dysfunctions due to the tRNALeu(UUR) A3243G mutation, associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms and diabetes.

Ronghua Li, Min-Xin Guan

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 133 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Associations between forensic loci and expression levels of neighboring genes may compromise medical privacy.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ronghua LiDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA.
Min-Xin Guan
Cincinnati Children's Hospital Medical Center · US

Funding

Molecular Mechanism of Aminoglycoside OtotoxicityR01DC005230 · NIDCD · CINCINNATI CHILDRENS HOSP MED CTR · PI GUAN, MIN-XIN · 2002 to 2006
$1.8M
Nuclear modifier genes for maternally inherited deafnessR01DC007696 · NIDCD · CINCINNATI CHILDRENS HOSP MED CTR · PI GUAN, MIN-XIN · 2007 to 2010
$1.3M
Genetic Correction of Maternally Inherited DiseasesR01NS044015 · NINDS · CHILDREN'S HOSPITAL MED CTR (CINCINNATI) · PI GUAN, MIN-XIN · 2002 to 2004
$525k
NIDCD NIH HHS R01 DC005230NIDCD NIH HHS R01 DC007696NIDCD NIH HHS R01DC05230NIDCD NIH HHS R01DC07696NINDS NIH HHS R01 NS044015NINDS NIH HHS R01NS44015
6 · The paper itself

Abstract

Mutations in mitochondrial tRNA genes are associated with a wide spectrum of human diseases. In particular, the tRNA(Leu(UUR)) A3243G mutation causes mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms (MELAS) and 2% of cases of type 2 diabetes. The primary defect in this mutation was an inefficient aminoacylation of the tRNA(Leu(UUR)). In the present study, we have investigated the molecular mechanism of the A3243G mutation and whether the overexpression of human mitochondrial leucyl-tRNA synthetase (LARS2) in the cytoplasmic hybrid (cybrid) cells carrying the A3243G mutation corrects the mitochondrial dysfunctions. Human LARS2 localizes exclusively to mitochondria, and LARS2 is expressed ubiquitously but most abundantly in tissues with high metabolic rates. We showed that the alteration of aminoacylation tRNA(Leu(UUR)) caused by the A3243G mutation led to mitochondrial translational defects and thereby reduced the aminoacylated efficiencies of tRNA(Leu(UUR)) as well as tRNA(Ala) and tRNA(Met). We demonstrated that the transfer of human mitochondrial leucyl-tRNA synthetase into the cybrid cells carrying the A3243G mutation improved the efficiency of aminoacylation and stability of mitochondrial tRNAs and then increased the rates of mitochondrial translation and respiration, consequently correcting the mitochondrial dysfunction. These findings provide new insights into the molecular mechanism of maternally inherited diseases and a step toward therapeutic interventions for these disorders.

Indexed as

Genetic Predisposition to DiseaseCell Line, TumorCell RespirationDiabetes Mellitus, Type 2Gene Expression Regulation, EnzymologicHumansKineticsLeucine-tRNA LigaseMELAS SyndromeMitochondriaMutationProtein BiosynthesisProtein TransportRNA Processing, Post-TranscriptionalRNA, Transfer, LeuSubcellular FractionsLeucine-tRNA LigaseRNA, Transfer, Leu

Identifiers

PMID20194621
PMCPMC2863588
OpenAlexW2152538485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.